Response Biomedical Corp. (OTCBB: RPBIF) & (TSX.V: RBM)
Response Biomedical Initiates US Clinical Trials of RAMP NT-proBNP Test for the Diagnosis of Congestive Heart Failure
VANCOUVER, Aug. 3 /CNW/ – Response Biomedical Corporation (TSX-V: RBM, OTCBB: RPBIF) announced today it has begun patient enrollment at four leading sites in the United States for the purpose of demonstrating substantial equivalence of the RAMP NT-proBNP Test to a predicate device. The results of this multi-center clinical trial will form the basis for a US FDA 510(k) submission and European CE Certification. The four sites conducting the trials are the Mayo Clinic, Minneapolis Medical Research Foundation at Hennepin County Medical Center, Massachusetts General Hospital and San Francisco General Hospital.
Read full release here:
http://stockguru.com/profiles/rpbif/news.php
EntreMetrix Corporation (OTCBB: ERMX)
EntreMetrix Expands Its Venture Development Platform to Florida
IRVINE, CA–(MARKET WIRE)–Aug 3, 2006 — EntreMetrix, Inc. (OTC BB:ERMX.OB – News) today announced its plans to expand the Company’s Venture Development Platform by adding new venues for its popular Venture Dinner Forums. Scott W. Absher, EntreMetrix’s CEO, stated, “Our expansion into Florida has opened up the opportunity to bring our Venture Development Forum to an expanded audience. We have been actively meeting firms in Florida who, like EntreMetrix, share a passion for early stage opportunities. Our Venture Development Forum will provide platform to connect early stage companies with the early stage investment community.”
Read full release here:
http://stockguru.com/profiles/ermx/news.php
We Invite you to Visit the All New StockGuru Blog!
Here you will find updates on all our covered companies, including Profiled Companies and StockGuru Picks.
Click HERE to visit the Blog, or go to:
http://stockguru.com/blog/
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com. RPBIF Disclosure: Pentony Enterprises LLC was compensated a total of $12,500 for profile coverage from the company. ERMX Disclosure: Pentony Enterprises LLC was compensated $10,000 for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
P